Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-30), Business Alignment PCL's 3-1 Month Momentum % is N/A%.
The industry rank for Business Alignment PCL's 3-1 Month Momentum % or its related term are showing as below:
BKK:BIZ-R's 3-1 Month Momentum % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -6.21 * Ranked among companies with meaningful 3-1 Month Momentum % only.
Business Alignment PCL (BKK:BIZ-R) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Business Alignment PCL 3-1 Month Momentum % Related Terms
BKK:BIZ-R vs ABT, SYK, MDT: 3-1 Month Momentum % Comparison
For the Medical Devices subindustry, Business Alignment PCL's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Business Alignment PCL 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Business Alignment PCL's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Business Alignment PCL's 3-1 Month Momentum % falls into.
Business Alignment PCL (BKK:BIZ-R) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Business Alignment PCL (BKK:BIZ-R) has a 3-1 Month Momentum % of N/A% as of Aug. 30, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Business Alignment PCL and its competitors. According to the industry distribution chart, Business Alignment PCL ranks #89 out of 850 companies in the Medical Devices & Instruments industry, placing it in the top 10.5%.
Is Business Alignment PCL's 3-1 Month Momentum % too high?
Business Alignment PCL's current 3-1 Month Momentum % is N/A%. Based on the distribution chart, Business Alignment PCL ranks #89 out of 850 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Business Alignment PCL has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Business Alignment PCL's 3-1 Month Momentum % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Business Alignment PCL ranks #89 out of 850 companies for 3-1 Month Momentum %. This places Business Alignment PCL in the top 11% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Business Alignment PCL and its competitors. Business Alignment PCL's current 3-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Business Alignment PCL stock overvalued right now?
Business Alignment PCL (BKK:BIZ-R) has a current 3-1 Month Momentum % of N/A%. The stock's GF Value™ is ฿5.44, compared to a current price of ฿5.95 — trading 9.4% above its estimated fair value. The current 3-1 Month Momentum % is N/A%. Business Alignment PCL's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Business Alignment PCL (BKK:BIZ-R), the current 3-1 Month Momentum % is N/A% as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Business Alignment PCL (BKK:BIZ-R) Overvalued in 2026?
Based on GuruFocus' analysis, Business Alignment PCL stock appears to be overvalued.
The current stock price of ฿5.95 is trading 9.4% above its estimated GF Value™ of ฿5.44.
Key valuation signals for BKK:BIZ-R:
3-1 Month Momentum %: N/A%
GF Value™: ฿5.44 vs. price of ฿5.95 (9.4% above fair value)
No single metric tells the full story. See the BKK:BIZ-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Business Alignment PCL is engaged in the distribution and installation of medical equipment for cancer treatment through radiotherapy. The company operates through the sale of medical equipment segment which includes installation, repair, and maintenance. In addition, it also focuses on increasing the efficiency of medical equipment; and Hospital operations (specialized in cancer treatment). The company is a distributor for Radiotherapy products and Brachytheraphy products in Thailand and Cambodia. Geographically, it operates in the region of Thailand.
91GF Score
Get the complete analysis for BKK:BIZ-R
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BIZ-R has been successfully added to your 
